Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001144204-08-071606
Filing Date
2008-12-31
Accepted
2008-12-30 17:50:11
Documents
8
Period of Report
2008-10-30
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 v135633_8ka.htm 8-K/A 42821
2 v135633_ex15-1.htm EX-15.1 43413
3 v135633_ex15-2.htm EX-15.2 19913
4 v135633_ex16-1.htm EX-16.1 521
5 GRAPHIC v135633_ex16-1x1x1.jpg GRAPHIC 36459
6 v135633_ex99-1.htm EX-99.1 152779
7 GRAPHIC logo.jpg GRAPHIC 8374
8 GRAPHIC sig.jpg GRAPHIC 9855
  Complete submission text file 0001144204-08-071606.txt   336796
Mailing Address 1635 VILLAGE CENTER CIRCLE SUITE 250 LAS VEGAS NV 89134
Business Address 1635 VILLAGE CENTER CIRCLE SUITE 250 LAS VEGAS NV 89134 702-248-1174
CardioVascular BioTherapeutics, Inc. (Filer) CIK: 0001303497 (see all company filings)

EIN.: 330795984 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 000-51172 | Film No.: 081276598
SIC: 2834 Pharmaceutical Preparations